Creation of a restrictive atrial communication in heart failure with preserved and mid-range ejection fraction: effective palliation of left atrial hypertension and pulmonary congestion

Clinical Research in Cardiology

Volumn 107, Issue 9, 2018, Pages 845-857

  Bauer, Anna ^a   Khalil, Markus ^a   Lüdemann, Monika ^a   Bauer, Jürgen ^a   Esmaeili, Anoosh ^b   De Rosa, Roberta ^c   Voelkel, Norbert F ^d   Akintuerk, Hakan ^a   Schranz, Dietmar ^a,b  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY OF SALERNO   (Italy)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atrial septostomy, restrictive atrial communication; Diastolic heart failure; Preserved ejection fraction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DIAZEPAM; KETAMINE; MIDAZOLAM;

ADOLESCENT; ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; CARDIOMYOPATHY; CHILD; COHORT ANALYSIS; COMBINED POST CAPILLARY PULMONARY HYPERTENSION; CONGENITAL HEART DISEASE; CONGENITAL HEART MALFORMATION; DISEASE ASSOCIATION; FEMALE; FEMORAL ARTERIAL ACCESS; FLUOROSCOPY; HEART EJECTION FRACTION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART HEMODYNAMICS; HEART LEFT ATRIUM PRESSURE; HEART LUNG TRANSPLANTATION; HEART OUTPUT; HEART RIGHT ATRIUM PRESSURE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; INFANT; LUNG ARTERY PRESSURE; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR DECOMPRESSION; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; NEW YORK HEART ASSOCIATION CLASS; OBSERVATIONAL STUDY; OXYGEN SATURATION; PALLIATIVE THERAPY; PERCUTANEOUS CORONARY INTERVENTION; PULSE OXIMETRY; RESTRICTIVE CARDIOMYOPATHY; RETROSPECTIVE STUDY; SUPERIOR CAVA VEIN; TRANSPULMONARY PRESSURE GRADIENT; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; COMPLICATION; DIAGNOSTIC IMAGING; DIASTOLE; HEART ATRIUM APPENDAGE; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART SURGERY; HEART VENTRICLE; HEART VENTRICLE PRESSURE; LUNG EDEMA; LUNG WEDGE PRESSURE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ATRIAL APPENDAGE; CARDIAC CATHETERIZATION; CARDIAC SURGICAL PROCEDURES; CHILD; CHILD, PRESCHOOL; DIASTOLE; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; HYPERTENSION; INFANT; MALE; MIDDLE AGED; PALLIATIVE CARE; PULMONARY EDEMA; PULMONARY WEDGE PRESSURE; RETROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE; YOUNG ADULT;

EID: 85045433740     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-018-1255-x     Document Type: Article

References (35)

1. Towbin JA, Bowles NE (2002) The failing heart. Nature 415:227–233
2. Gerber Y, Weston SA, Redfield MM, Chamberlain AM, Manemann SM, Jiang R, Killian JM, Roger VL (2015) A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med 175:996–1004
3. Borlaug BA, Redfield MM (2011) Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation 123:2006–2013
4. Tschöpe C, Birner C, Böhm M, Bruder O, Frantz S, Luchner A, Maier L, Störk S, Kherad B, Laufs U (2018) Heart failure with preserved ejection fraction: current management and future strategies: Expert opinion on the behalf of the Nucleus of the “Heart Failure Working Group” of the German Society of Cardiology (DKG). Clin Res Cardiol 107(1):1–19
5. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JC, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, ESC Scientific Document Group (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC European. Heart J 37:27, 14 2129–2200
6. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumache, Chandrasekaran K, Solomon SD, Louie EK, Schiller MD (2010) NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23:685–713
7. Burns KM, Byrne BJ, Gelb BD, Kühn B, Leinwand LA, Mital S, Pearson GD, Rodefeld M, Rossano JW, Stauffer BL, Taylor MD, Towbin JA, Redington AN (2014) New mechanistic and therapeutic targets for pediatric heart failure: report from a National Heart, Lung, and Blood Institute working group. Circulation 130(1):79–86
8. Masarone D, Valente F, Rubino M, Vastarella R, Gravino R, Rea A, Russo MG, Pacileo G, Limongelli G (2017) Pediatric heart failure: a practical guide to diagnosis and management. Pediatr Neonatol 58:303–312
9. Masutani S, Little WC, Hasegawa H, Cheng HJ, Cheng CP (2008) Restrictive left ventricular filling pattern does not result from increased left atrial pressure alone. Circulation 117:1550–1554
10. Ouzounian M, Lee DS, Liu PP (2008) Diastolic heart failure: mechanisms and controversies. Nat Clin Pract Cardiovasc Med 5:375–386
11. Masutani S, Saiki H, Kurishima C, Ishido M, Tamura M, Senzaki H (2013) Heart failure with preserved ejection fraction in children. Circ J 77:2375–2382
12. Palazzuoli A, Ruocco G, Beltrami M, Nuti R, Cleland JG (2018) Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF. Clin Res Cardiol. 10.1007/s00392-018-1221-7 [Epub ahead of print]
13. Morbach C, Buck T, Rost C, Peter S, Günther S, Störk S, Prettin C, Erbel R, Ertl G, Angermann CE (2018) Point-of-care B-type natriuretic peptide and portable echocardiography for assessment of patients with suspected heart failure in primary care: rationale and design of the three-part Handheld-BNP program and results of the training study. Clin Res Cardiol 107(2):95–107
14. Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, Aboyans V, Vaz Carneiro A, Achenbach S, Agewall S, Allanore Y, Asteggiano R, Paolo Badano L, Albert Barbera J, Bouvaist H, Bueno H, Byrne RA, Carerj S, Castro G, Erol C, Falk V, Funck-Brentano C, Gorenflo M, Granton J, Iung B, Kiely DG, Kirchhof P, Kjellstrom B, Landmesser U, Lekakis J, Lionis C, Lip GY, Orfanos SE, Park MH, Piepoli MF, Ponikowski P, Revel MP, Rigau D, Rosenkranz S, Voller H, Luis Zamorano J (2016) 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37:67–119
15. Ritzema J, Troughton R, Melton I, Crozier I, Doughty R, Krum H, Walton A, Adamson P, Kar S, Shah PK, Richards M, Eigler NL, Whiting JS, Haas GJ, Heywood JT, Frampton CM, Abraham WT, Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients Study G (2010) Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation 121:1086–1095
16. Bistola V, Simitsis P, Farmakis D, Ikonomidis I, Bakosis G, Triposkiadis F, Hatziagelaki E, Lekakis J, Mebazaa A, Parissis J (2018) Association of mineralocorticoid receptor antagonist use and in-hospital outcomes in patients with acute heart failure. Clin Res Cardiol 107(1):76–86
17. Ellison DH, Felker GM (2017) Diuretic treatment in heart failure. N Engl J Med 377:1964–1975
18. Schranz D (2018) Diuretic treatment in heart failure—optimizing or avoiding? N Engl J Med 15(7):683 378
19. Del Trigo M, Bergeron S, Bernier M, Amat-Santos IJ, Puri R, Campelo-Parada F, Altisent OA, Regueiro A, Eigler N, Rozenfeld E, Pibarot P, Abraham WT, Rodes-Cabau J (2016) Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study. Lancet 387:1290–1297
20. Hasenfuss G, Hayward C, Burkhoff D, Silvestry FE, McKenzie S, Gustafsson F, Malek F, Van der Heyden J, Lang I, Petrie MC, Cleland JG, Leon M, Kaye DM, investigators RL-Hs (2016) A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet 387:1298–1304
21. Kaye DM, Hasenfuss G, Neuzil P, Post MC, Doughty R, Trochu JN, Kolodziej A, Westenfeld R, Penicka M, Rosenberg M, Walton A, Muller D, Walters D, Hausleiter J, Raake P, Petrie MC, Bergmann M, Jondeau G, Feldman T, Veldhuisen DJ, Ponikowski P, Silvestry FE, Burkhoff D, Hayward C (2016) One-year outcomes after transcatheter insertion of an interatrial shunt device for the management of heart failure with preserved ejection fraction. Circ Heart Fail 9:e003662
22. Hoffmann R, Altiok E, Reith S, Brehmer K, Almalla M (2014) Functional effect of new atrial septal defect after percutaneous mitral valve repair using the MitraClip. Device Am J Cardiol 113:1228e-1233
23. Guazzi M, Borlaug BA (2012) Pulmonary hypertension due to left heart disease. Circulation 126:975–990
24. Naeije R, Vachiery JL, Yerly P, Vanderpool R (2013) The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease. Eur Respir J 41(1):217–223
25. Schranz D, Bauer A, Reich B, Steinbrenner B, Recla S, Schmidt D, Apitz C, Thul J, Valeske K, Bauer J, Müller M, Jux C, Michel-Behnke I, Akintürk H (2015) Fifteen-year single center experience with the “Giessen Hybrid” approach for hypoplastic left heart and variants: current strategies and outcomes. Pediatr Cardiol 36:365–373
26. Rupp S, Michel-Behnke I, Valeske K, Akintürk H, Schranz D (2007) Implantation of stents to ensure an adequate interatrial communication in patients with hypoplastic left heart syndrome. Cardiol Young 17(5):535–540
27. Schranz B, Akintuerk H, Voelkel NF (2017) ‘End-stage’ heart failure therapy: potential lessons from congenital heart disease: from pulmonary artery banding and interatrial communication to parallel circulation. Heart 103(4):262–267
28. Latus H, Apitz C, Schmidt D, Jux C, Müller M, Bauer J, Akintuerk H, Schneider M, Schranz D (2013) Potts shunt and atrioseptostomy in pulmonary hypertension due to left ventricular disease. Ann Thorac Surg 96:317–319
29. Rupp S, Thul J, Gummel K, Khalil M, Akintuerk H, Schranz D (2017) Surgical-interventional hybrid concert in a newborn with borderline left heart. Ann Thorac Surg 104(1):e71-e73
30. Moysich A, Gunter Kerst G, Hakan Akintürk H, Schranz D (2015) Successful transapical Melody valve implant in mitral bioprothesis in a 3-year old child with dextrocardia and Fontan palliation. JTCVS 150(2):e23–e25
31. Rosca M, Lancellotti P, Popescu BA, Pierard LA (2011) Left atrial function: pathophysiology, echocardiographic assessment, and clinical applications. Heart 97:1982–1989
32. Abbate A, Arena R, Abouzaki N, Van Tassell BW, Canada J, Shah K, Biondi-Zoccai G, Voelkel NF (2015) Heart failure with preserved ejection fraction: refocusing on diastole. Int J Cardiol 179:430–40
33. Richartz BM1, Werner GS, Ferrari M, Figulla HR (2002) Comparison of left ventricular systolic and diastolic function in patients with idiopathic dilated cardiomyopathy and mild heart failure versus those with severe heart failure. Am J Cardiol 90(4):390–394
34. Tan YT, Wenzelburger F, Lee E et al (2009) The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. J Am Coll Cardiol 54:36–46
35. Feldman T, Mauri L, Kahwash R, Litwin S, Ricciardi MJ, van der Harst P, Penicka M, Fail PS, Kaye DM, Petrie MC, Basuray A, Hummel SL, Forde-McLean R, Nielsen CD, Lilly S, Massaro JM, Burkhoff D, Shah SJ, for the REDUCE LAP-HF I Investigators (2018) A transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I): a phase 2, randomized, sham-controlled trial. Circulation 137(4):364–375